Diagnostic of Human Immunodeficiency Virus (HIV) and Other Sexual Transmission Diseases (STD) in High Risk Populations: Men Who Have Sex With Men (MSM) Users of Chemsex

HIV Clinical Trial

— Care_ChemS  

Official title:

Diagnostic of Human Immunodeficiency Virus (HIV) and Other Sexual Transmission Diseases (STD) in High Risk Populations: Men Who Have Sex With Men (MSM) Users of Chemsex

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT03546140
• Other study ID #: Care_ChemS_ClinC -001-2017
• Status: Not yet recruiting
• Start date: June 2018
• Est. completion date: June 2021

Study information

• Verified date: June 2018
• Source: Fundacion Clinic per a la Recerca Biomédica
• Contact: Anna Cruceta, MD
• Phone: 932275400
• Email: acruceta[@]clinic.ub.es
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The main objective is to offer diagnostic tests for HIV, HCV and other STD in the risk group of men having sex with men (MSM) users of Chemsex

Description:

The main objective is to offer diagnostic tests for HIV, HCV and other STD in the risk group (MSM users of Chemsex) with the purpose of conduct diagnosis, early treatment and monitoring of this infections and reduce the incidence rate of the same ones

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 500
• Est. completion date: June 2021
• Est. primary completion date: August 2020
• Accepts healthy volunteers: No
• Gender: Male
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Adults (= 18 years)

• Men MSM/transgender referred from PEP office

• Men MSM/transgender referred from urgency service attended for acute intoxication or an STD

• Men MSM/transgender referred from STD office

• Men MSM/transgender referred from a local ONG attended for chemsex use

• Specifically drug use for having sexual relations, at least once in a month in the lasts 6 months or more than 10 times the last year

• Reading and understanding ability

• Patients should be given written informed consent

• Negative HIV and HCV men

• HIV positive men but HIC negative referred from HIV daily hospital

• Disposal of sanitary card from CatSalut

Exclusion Criteria:

• Men that not accomplish inclusion criteria

• Drug use for another purposes not sexual

• Drug use for having occasional sexual relations, least than once in the past 6 months

Related Conditions & MeSH terms

• Acquired Immunodeficiency Syndrome
• HIV
• HIV Infections
• Immunologic Deficiency Syndromes

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Fundacion Clinic per a la Recerca Biomédica

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of HIV,	HIV positive serology	2 years
Primary	number of HCV seroconversion	HCV positive serology	2 years
Primary	number STD seroconversion	positive serology	2 years
Secondary	type of consumer drug	number and name ( Visual Analog Score for drug)	2 years
Secondary	clinical outcomes	number of hospital admissions for acute intoxications	2 years
Secondary	analytical outcomes	VDRL serology	2 years
Secondary	analytical outcomes	PCR CT/GN(pharynx / urethra / anus)	2 years
Secondary	weight	in kilograms	2 years